Psychiatry & Neurology Doctors in Rochester, NH Accepting Medicare

3 Psychiatry & Neurology doctors found. Showing 1 - 3

Dr. Susan Reid, Psychiatry & Neurology - Geriatric Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 11 Whitehall Rd, Rochester, NH 03867 Phone: 603-332-5211

Dr. Robert J Allister, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 25 Old Dover Rd, Rochester, NH 03867 Phone: 603-335-6470    Fax: 603-335-9278

Ms. Namratha Reddy Boda, M.D. Psychiatry & Neurology - Geriatric Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 11 Whitehall Rd, Rochester, NH 03867 Phone: 603-330-7931    Fax: 603-335-8199

News Archive

Boehringer Ingelheim advances into Phase 3 clinical trial of BI 201335

Boehringer Ingelheim today announced a preview of the study designs for the pivotal Phase 3 clinical trials evaluating BI 201335, its investigational once-daily oral protease inhibitor, in both treatment-naive and -experienced patients with chronic genotype-1 hepatitis C virus, the most challenging genotype to treat.

Researchers identify possible prognostic biomarker in triple-negative breast cancer

"Triple-negative" breast cancer (TNBC) occurs in patients whose cells do not express receptors for estrogen, progesterone, and/or human epidermal growth factor receptor 2 (ER-/PR-/HER2-).

Data from phase III trials supports safety, efficacy of linagliptin in treating T2D in African-American adults

Data from a retrospective pooled analysis of eight phase III trials (two 18-week and six 24-week) of linagliptin 5 mg once-daily, showed reductions from baseline A1c at 18 (eight trials) and 24 (six trials) weeks compared to placebo in African-American adults with type 2 diabetes (T2D),

Older women with metastatic breast cancer more likely to have genetic alterations in tumors

A University of North Carolina Lineberger Comprehensive Cancer Center-led analysis has found that women who are 65 years or older with metastatic breast cancer were more likely to have a cancer-linked genetic alterations in their tumors, and had a larger total number of genetic alterations, than younger patients overall.

Read more Medical News

› Verified 7 days ago